2021 American Transplant Congress
Covid-19-related Knowledge, Health Behaviors and Attitudes Towards Telemedicine and Emergency Visits in a Population of Kidney Transplant (KTx) Recipients
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: We explored knowledge about COVID-19 and attitudes towards emergency care and telemedicine visits in a population of inner-city KTx pts.*Methods: A telephone survey was…2021 American Transplant Congress
Evaluation of Fungal Prophylaxis Post-Lung Transplantation
1Temple University Hospital, Philadelphia, PA, 2Temple School of Pharmacy, Philadelphia, PA
*Purpose: Fungal infections are responsible for approximately 15-35% of all infections in lung transplant recipients; 80% of which are due to aspergillus or candida. At…2021 American Transplant Congress
Clinical Outcomes of Solid Organ Transplant Recipients Treated with Remdesivir and Convalescent Plasma for Covid-19 at the Largest Transplant Center in the United States
Miami Transplant Institute, Jackson Health System, Miami, FL
*Purpose: Solid organ transplant recipients (SOTr) are at high risk for severe disease with SARS-CoV-2. Data on efficacy of potential treatment options and long-term outcomes…2021 American Transplant Congress
Infectious Complications After Belatacept Conversion in Kidney Transplant
*Purpose: Tacrolimus (tac), a calcineurin inhibitor, is associated with multiple adverse effects when used for immunosuppression following kidney transplant (KT). Belatacept (bela) is a monoclonal…2021 American Transplant Congress
Outcomes of Novel Coronavirus 2019 in Solid Organ Transplant Recipients: Yet Again, Race and Payor Status Matters
*Purpose: By the early spring of 2020, the United States has become the global epicenter of the coronavirus 2019 (COVID-19) pandemic. Little is known if…2021 American Transplant Congress
An Evaluation of Pjp Prophylaxis and Anemia Among Renal Transplant Recipients
NewYork-Presbyterian Hospital, New York, NY
*Purpose: Dapone and atovaquone are therapeutic options for PJP prophylaxis in renal transplant recipients. The objective of this study was to evaluate the incidence of…2021 American Transplant Congress
Covid-19 Reinfection in a Kidney Transplant Patient
Nephrology, Yale School of Medicine, New Haven, CT
*Purpose: Several cases have demonstrated positive SARS-CoV-2 PCR testing in patients who were initially shown to have cleared the infection. These reinfections may represent new…2021 American Transplant Congress
Covid 19 Re-infection versus Re-activation in Two Renal Transplant Patients
Montefiore Medical Center, New York, NY
*Purpose: Rare cases of potential COVID 19 re-infection have been reported throughout the world.*Methods: We describe two renal transplant recipients with possible SARS-COV-2 re-infection.*Results: Patient…2021 American Transplant Congress
Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection
Pharmacy, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Rabbit antithymocyte globulin (rATG) is FDA approved for kidney transplant induction therapy and treatment of T-cell mediated rejection (TCMR). While prior studies comparing dosing…2021 American Transplant Congress
Impact of Bacterial Infection on HLA Allosensitization Among Kidney Recipients on the Waitlist
*Purpose: The clinical relevance of HLA allosensitization associated with bacterial infection remains poorly defined. The primary objective of this study is to determine the incidence,…
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 84
- Next Page »